The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
Open accessAbstract
Ependymomas are common childhood brain tumours that occur throughout the nervous system, but are most common in the paediatric hindbrain. Current standard therapy comprises surgery and radiation, but not cytotoxic chemotherapy as it does not further increase survival. Whole-genome and whole-exome sequencing of 47 hindbrain ependymomas reveals an extremely low mutation rate, and zero significant recurrent somatic single nucleotide variants. Although devoid of recurrent single nucleotide variants and focal copy number aberrations, poor-prognosis hindbrain ependymomas exhibit a CpG island methylator phenotype. Transcriptional silencing driven by CpG methylation converges exclusively on targets of the Polycomb repressive complex 2 which represses expression of differentiation genes through trimethylation of H3K27. CpG island methylator phenotype-positive hindbrain ependymomas are responsive to clinical drugs that target either DNA or H3K27 methylation both in vitro and in vivo. We conclude that epigenetic modifiers are the first rational therapeutic candidates for this deadly malignancy, which is epigenetically deregulated but genetically bland.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“many of the enzymes targeted, particularly lysine and arginine methyltransferases, have non-histone substrates”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [183]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Román‐Gómez, J., Jiménez‐Velasco, A., Agirre, X., Prósper, F., Heiniger, A., & Torres, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4944 · Cited by 128
RetractedComprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationThe Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Self-citationComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Self-citationDriver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
Self-citationA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Ben‐Porath, I., Thomson, M., Carey, V. J., Ge, R., Bell, G. W., Regev, A., & Weinberg, R. A. (2008) · Nature Genetics · doi:10.1038/ng.127 · Cited by 2,571
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 608
Zaman, W. S. W. K., Nurul, A. A., & Nordin, F. (2021) · Biomedicines · doi:10.3390/biomedicines9091245 · Cited by 17
Cheng, D., Zhuo, Z., Du, J., Weng, J., Zhang, C., Duan, Y., Sun, T., Wu, M., Guo, M., Hua, T., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1461 · Cited by 17
Molecular Basis of Pediatric Brain Tumors
Κλώνου, Α., Piperi, C., Gargalionis, A. N., & Papavassiliou, A. G. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8455-9 · Cited by 17
Pediatric Ependymoma: Current Treatment and Newer Therapeutic Insights
Khatua, S., Mangum, R., Bertrand, K. C., Zaky, W. T., McCall, D. C., & Mack, S. C. (2018) · Future Oncology · doi:10.2217/fon-2018-0502 · Cited by 17
Self-citationMedulloblastoma epigenetics and the path to clinical innovation
Haltom, A. R., Toll, S. A., Cheng, D., Maegawa, S., Gopalakrishnan, V., & Khatua, S. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03591-9 · Cited by 17
Radiohistogenomics of pediatric low-grade neuroepithelial tumors
Bag, A. K., Chiang, J., & Patay, Z. J. (2021) · Neuroradiology · doi:10.1007/s00234-021-02691-1 · Cited by 17
Zaytseva, M., Papusha, L. I., Novichkova, G. A., & Druy, A. E. (2021) · Cancers · doi:10.3390/cancers13194954 · Cited by 17
Foss-Skiftesvik, J., Stoltze, U. K., Hansen, T. V. O., Ahlborn, L. B., Sørensen, E., Ostrowski, S. R., Kullegaard, S. M. A., Laspiur, A. O., Melchior, L. C., Scheie, D., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01429-1 · Cited by 17
Advances on Epigenetic Drugs for Pediatric Brain Tumors
Skouras, P., Markouli, M., Strepkos, D., & Piperi, C. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220922150456 · Cited by 16
Assaying the epigenome in limited numbers of cells
Greenleaf, W. J. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.010 · Cited by 16
Disruption of circadian clockwork in in vivo reprogramming‐induced mouse kidney tumors
Ohashi, M., Umemura, Y. M., Koike, N., Tsuchiya, Y., Inada, Y., Watanabe, H., Tanaka, T., Minami, Y., Ukimura, O., Miki, T., et al. (2017) · Genes to Cells · doi:10.1111/gtc.12552 · Cited by 16
Chromatin remodeling defects in pediatric brain tumors
Κλώνου, Α., Spiliotakopoulou, D., Themistocleous, M. S., Piperi, C., & Papavassiliou, A. G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.08 · Cited by 16
A little piece of mind: best practices for brain tumor intraoperative consultation
Fuller, C. E. (2018) · Modern Pathology · doi:10.1038/s41379-018-0147-y · Cited by 16
Microfluidic epigenomic mapping technologies for precision medicine
Deng, C., Naler, L. B., & Lu, C. (2019) · Lab on a Chip · doi:10.1039/c9lc00407f · Cited by 17
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
Gatto, L., Franceschi, E., Tosoni, A., Nunno, V. D., Bartolini, S., & Brandes, A. A. (2022) · Cancers · doi:10.3390/cancers14020333 · Cited by 16
Recurrent ACVR1 mutations in posterior fossa ependymoma
Pratt, D. W., Lucas, C. G., Selvam, P., Abdullaev, Z., Ketchum, C., Quezado, M., Armstrong, T. S., Gilbert, M. R., Papanicolau‐Sengos, A., Raffeld, M. A., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02435-2 · Cited by 16
Self-citationMadubata, C. J., Alireza Roshan-ghias, A., Chu, T. H., Resnick, S. J., Zhao, J., Arnes, L., Wang, J., & Rabadán, R. (2017) · npj Genomic Medicine · doi:10.1038/s41525-017-0032-5 · Cited by 17
Nambirajan, A., Malgulwar, P. B., Sharma, A., Boorgula, M. T., Doddamani, R. S., Singh, M., Suri, V. S., Sarkar, C., & Sharma, M. C. (2019) · Brain Tumor Pathology · doi:10.1007/s10014-019-00350-1 · Cited by 16
Stücklin, A. G., & Grotzer, M. A. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64189-2.00019-6 · Cited by 16
Gupta, K., & Salunke, P. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9646-8 · Cited by 15
Miller, C. A., Dahiya, S. M., Li, T., Fulton, R. S., Smyth, M. D., Dunn, G. P., Rubin, J. B., & Mardis, E. R. (2018) · Molecular Case Studies · doi:10.1101/mcs.a002444 · Cited by 13
Personalised cancer care: promises and challenges of targeted therapy
Tu, S., Bilen, M. A., & Tannir, N. M. (2016) · Journal of the Royal Society of Medicine · doi:10.1177/0141076816631154 · Cited by 15
Yonezawa, U., Karlowee, V., Amatya, V. J., Takayasu, T., Takano, M., Takeshima, Y., Sugiyama, K., Kurisu, K., & Yamasaki, F. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.05.063 · Cited by 14
Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline
Lim-Fat, M. J., MacDonald, M., Lapointe, S., Climans, S., Cacciotti, C., Chahal, M., Perreault, S., Tsang, D. S., Gao, A. F., Yip, S. S. F., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.960509 · Cited by 15
Self-citationChen, C., Chen, L., Yao, Y., Qin, Z., & Chen, H. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-2007-7 · Cited by 14
Self-citationComputational morphogenesis – Embryogenesis, cancer research and digital pathology
Siregar, P., Julen, N., Hufnagl, P., & Mutter, G. L. (2018) · Biosystems · doi:10.1016/j.biosystems.2018.05.006 · Cited by 14
Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma
Liu, S. J., Magill, S. T., Vasudevan, H. N., Hilz, S., Villanueva-Meyer, J. E., Lastella, S., Daggubati, V., Spatz, J., Choudhury, A., Orr, B. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.018 · Cited by 15
Novel fusion genes and chimeric transcripts in ependymal tumors
Olsen, T. K., Panagopoulos, I., Gorunova, L., Micci, F., Andersen, K., Andersen, H. K., Meling, T. R., Due‐Tønnessen, B. J., Scheie, D., Heim, S., et al. (2016) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22392 · Cited by 14
Essentially all models are wrong, but some are useful
Simard, J. M. (2015) · Neurology · doi:10.1212/wnl.0000000000001769 · Cited by 13
Microfluidic Barcode Biochips for High-Throughput Real-Time Biomolecule and Single-Cell Screening
Qiu, J., Liang, Y., Wang, C., Yu, Y., Zhang, Y., Liu, H., & Han, L. (2024) · Engineering · doi:10.1016/j.eng.2024.06.016 · Cited by 13
Guillermin, Y., Lopez, J., Chabane, K., Hayette, S., Bardel, C., Salles, G. A., Sujobert, P., & Huet, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041251 · Cited by 15
Treatment Decisions of World Health Organization Grade II and III Ependymomas in Molecular Era
Jung, T., Jung, S., Kook, H., & Baek, H. (2018) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2018.0003 · Cited by 13
Rogers, H. A., Chapman, R. J., Kings, H., Allard, J., Barron-Hastings, J., Pajtler, K. W., Sill, M., Pfister, S. M., & Grundy, R. G. (2018) · Oncotarget · doi:10.18632/oncotarget.26370 · Cited by 13
Self-citationLiu, J., Tang, L., Yi, J., Li, G., Lu, Y.-W., Xu, Y., Zhao, S., Mao, R., Li, X., Ren, L., et al. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1086-x · Cited by 13
Takadera, M., Satomi, K., Szulzewsky, F., Cimino, P. J., Holland, E. C., Yamamoto, T., Ichimura, K., & Ozawa, T. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01080-8 · Cited by 13
Epigenetic mechanisms in paediatric brain tumours: regulators lose control
Badodi, S., & Marino, S. (2022) · Biochemical Society Transactions · doi:10.1042/bst20201227 · Cited by 13
The Molecular Landscape of Pediatric Brain Tumors in the Next-Generation Sequencing Era
Firme, M. R., & Marra, M. A. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0474-4 · Cited by 13
Self-citationConvergence of dispersed regulatory mutations predicts driver genes in prostate cancerPreprint
Sallari, R. C., Sinnott-Armstrong, N., French, J. D., Kron, K. J., Ho, J., Moore, J. H., Stambolic, V., Edwards, S. L., Lupien, M., & Kellis, M. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/097451 · Cited by 12
Self-citationLagan, E., Gannon, D., Silva, A. J., Bibawi, P., Doherty, A. M., Nimmo, D., McCole, R., Monger, C., Genesi, G. L., Vanderlinden, A., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.04.026 · Cited by 16
Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers
Arakaki, A. K. S., Szulzewsky, F., Gilbert, M. R., Gujral, T. S., & Holland, E. C. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab183 · Cited by 13
Santi, M., Viaene, A. N., & Hawkins, C. E. (2022) · Pediatric and Developmental Pathology · doi:10.1177/10935266211018928 · Cited by 12
Self-citationSexton‐Oates, A., MacGregor, D. P., Dodgshun, A. J., & Saffery, R. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv024 · Cited by 12
Ma, S., Li, C., Agazzi, S., & Jia, W. (2019) · Pediatric Neurosurgery · doi:10.1159/000495809 · Cited by 12
Global Reduction of H3K4me3 Improves Chemotherapeutic Efficacy for Pediatric Ependymomas
Lewis, R., Li, Y. D., Hoffman, L. M., Hashizume, R., Gravohac, G., Rice, G., Wadhwani, N. R., Jie, C., Pundy, T., Mania-Farnell, B. L., et al. (2019) · Neoplasia · doi:10.1016/j.neo.2019.03.012 · Cited by 12
A long-term survivor of pediatric midline glioma with H3F3A K27M and BRAF V600E double mutations
Nakano, Y., Yamasaki, K., Sakamoto, H., Matsusaka, Y., Kunihiro, N., Fukushima, H., Inoue, T., Honda‐Kitahara, M., Hara, J., Yoshida, A., et al. (2019) · Brain Tumor Pathology · doi:10.1007/s10014-019-00347-w · Cited by 12
Aichmüller, C., Iskar, M., Jones, D., Korshunov, A., Radlwimmer, B., Kool, M., Ernst, A., Pfister, S. M., Lichter, P., & Zapatka, M. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa035 · Cited by 12
Self-citationWang, G., Jia, Y., Ye, Y., Kang, E., Chen, H., Wang, J., & He, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02834-1 · Cited by 13
A novel pathogenic classification of cancers
Sonnenschein, C., Davis, B. J., & Soto, A. M. (2014) · Cancer Cell International · doi:10.1186/s12935-014-0113-9 · Cited by 14
Pediatric brain tumors: A neuropathologist's approach to the integrated diagnosis
Viaene, A. N. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1143363 · Cited by 11
Human Patient-Derived Brain Tumor Models to Recapitulate Ependymoma Tumor Vasculature
Tang‐Schomer, M. D., Bookland, M. J., Sargent, J. E., & Jackvony, T. N. (2023) · Bioengineering · doi:10.3390/bioengineering10070840 · Cited by 11
Practical immunomodulatory landscape of glioblastoma multiforme (GBM) therapy
Norollahi, S. E., Yousefi, B., Nejatifar, F., Yousefzadeh-Chabok, S., Rashidy‐Pour, A., & Samadani, A. A. (2024) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-024-00240-4 · Cited by 11
Optimizing outcomes in intracranial ependymoma: a contemporary review
Pan, Z., Bao, J., & Wei, S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1617169 · Cited by 11
Le cancer et ses gènes insaisissables
Sonnenschein, C., & Soto, A. M. (2014) · médecine/sciences · doi:10.1051/medsci/20143006022 · Cited by 11
Levine, A., Wong, D., Fatehi, M., & Yip, S. S. F. (2020) · Neurosurgery · doi:10.1093/neuros/nyaa329 · Cited by 11
microRNA network analysis identifies miR-29 cluster as key regulator of LAMA2 in ependymoma
Lourdusamy, A., Rahman, R., Smith, S. J., & Grundy, R. G. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0206-2 · Cited by 11
Wu, D., Wang, Y., Han, X., Wen, X., Wang, S., Shen, M., Fan, S., Zhuang, J., Zhang, Z.-F., Shan, Q., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26329 · Cited by 11
RetractedUpdate on Circumscribed Gliomas and Glioneuronal Tumors
Chen, J., & Dahiya, S. M. (2020) · Surgical pathology clinics · doi:10.1016/j.path.2020.02.004 · Cited by 11
Epigenetic actions of environmental factors and promising drugs for cancer therapy (Review)
Bai, Z., Bai, B., Zhu, J., Di, C., Li, X., & Zhou, W. (2017) · Oncology Letters · doi:10.3892/ol.2017.7597 · Cited by 11
Williams, J. S., Xu, B., Putnam, D. K., Thrasher, A., Li, C., Yang, J., & Chen, X. '. (2021) · Genome biology · doi:10.1186/s13059-020-02220-y · Cited by 12
Childhood Cerebellar Tumors Mirror Conserved Fetal Transcriptional ProgramsPreprint
Vladoiu, M. C., El-Hamamy, I., Donovan, L., Farooq, H., Holgado, B., Ramaswamy, V., Mack, S. C., Lee, J. J., Kumar, S. A., Przelicki, D., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/350280 · Cited by 11
Self-citationMolecular subgrouping of ependymoma across three anatomic sites and their prognostic implications
Chinnam, D., Gupta, K., Kiran, T., Saraswati, A., Salunke, P., Madan, R., Kumar, N., & Radotra, B. D. (2022) · Brain Tumor Pathology · doi:10.1007/s10014-022-00429-2 · Cited by 10
The DNA methylation landscape of five pediatric-tumor types
Parker, A., Quinteros, B., & Piccolo, S. (2022) · PeerJ · doi:10.7717/peerj.13516 · Cited by 11
Advances in the biology and treatment of pediatric central nervous system tumors
Vitanza, N. A., & Cho, Y. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000309 · Cited by 10
Self-citationNakamura, T., Fukuoka, K., Ikeda, J., Yoshitomi, M., Udaka, N., Tanoshima, R., Tateishi, K., Yamanaka, S., Ichimura, K., & Yamamoto, T. (2017) · Brain Tumor Pathology · doi:10.1007/s10014-017-0297-5 · Cited by 9
Rossi, S., Brenca, M., Zanatta, L., Trincia, E., Guerriero, A., Pizzato, C., Fiorindi, A., Viscardi, E., Giangaspero, F., Maestro, R., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly075 · Cited by 9
Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma
Wu, T., Zhang, Z., Li, S., Wang, B., Yang, Z., Li, P., Zhang, J., Tong, W., Li, C., Zhao, F. Q., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-0809-8 · Cited by 9
Antonelli, R., Jiménez, C., Riley, M. M., Servidei, T., Riccardi, R., Soriano, A., Roma, J. M., Martínez-Sáez, E. A., Martini, M., Ruggiero, A., et al. (2020) · Cancers · doi:10.3390/cancers12071922 · Cited by 9
Gao, H., Lin, S., Han, X., Xu, H., Gao, Y., & Qin, Z. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-935 · Cited by 9
Case Report: Sellar Ependymomas: A Clinic-Pathological Study and Literature Review
Zhao, L., Jiang, Y., Wang, Y., Bai, Y., Liu, L., & Li, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.551493 · Cited by 9
Servidei, T., Lucchetti, D., Navarra, P., Sgambato, A., Riccardi, R., & Ruggiero, A. (2021) · Cancers · doi:10.3390/cancers13236100 · Cited by 9
Posterior Fossa and Brainstem Tumors in Children
Alli, S. B., Işık, S., & Rutka, J. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-43140-8.00011-1 · Cited by 10
Self-citationNext-generation molecular diagnostics
Aldape, K., & Pfister, S. M. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802997-8.00007-4 · Cited by 8
Self-citationZheng, H., Baranova, K., Song, J. H., Yan, L., Biswas, S., Chakrabarti, S., & Zhang, Q. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa103 · Cited by 8
Rossetti, D. V., Massimi, L., Martelli, C., Vincenzoni, F., Silvestre, S. D., Scorpio, G., Tamburrini, G., Caldarelli, M., Urbani, A., & Desiderio, C. (2020) · Cancers · doi:10.3390/cancers12030674 · Cited by 8
Self-citationGupta, T., Patel, V., El-Medani, F., & Gupta, S. (2020) · Journal of Surgical Case Reports · doi:10.1093/jscr/rjaa177 · Cited by 8
Targeting the Cancer Epigenome with Histone Deacetylase Inhibitors in Osteosarcoma
Collier, C. D., Getty, P. J., & Greenfield, E. M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_4 · Cited by 9
Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups
Łastowska, M., Matyja, E., Sobocińska, A. A., Wojtaś, B., Niemira, M., Szałkowska, A., Kretowski, A. J., Karkucińska‐Więckowska, A., Kaleta, M., Ejmont, M., et al. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.236 · Cited by 8
Self-citationPractical Implications of the Updated WHO Classification of Brain Tumors
Sahm, F., & Martinez‐Lage, M. (2018) · Seminars in Neurology · doi:10.1055/s-0038-1641162 · Cited by 8
Malignant Brain Tumours in Children : Present and Future Perspectives
Rutka, J. T. (2018) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2018.0044 · Cited by 8
Self-citationAdult Primary Brain Neoplasm, Including 2016 World Health Organization Classification
Wang, K. Y., Chen, M., & Lincoln, C. M. M. (2020) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2020.09.011 · Cited by 8
Thomas, P. B., Jeffery, P. L., Gahete, M. D., Whiteside, E., Walpole, C., Maugham, M., Jovanovic, L., Gunter, J. H., Williams, E. D., Nelson, C. C., et al. (2021) · PeerJ · doi:10.7717/peerj.10280 · Cited by 8
Significance of DNA methylation assessment in the morphological diagnosis of brain tumours
Ryzhova, M. V., Galstyan, S. A., & Телышева, Е. Н. (2022) · Russian Journal of Archive of Pathology · doi:10.17116/patol20228403165 · Cited by 8
Self-citationWhat Is the Main Cause of Cancer?Preprint
López‐Lázaro, M. (2016) · Preprints.org · doi:10.20944/preprints201608.0130.v1 · Cited by 8
Prostate cancer cells converge to an inflammatory-like state upon metastatic dissemination
Keshavarzian, T., Furlano, K., Grillo, G., Mout, L., Arlidge, C., Hasan, F., Nand, A., Mikutenaite, M., Karadoulama, E., Goyal, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67856-5 · Cited by 7
Self-citationUnderstanding the Deadly Silence of Posterior Fossa A Ependymoma
Lin, G. L., & Monje, M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.020 · Cited by 7
In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma
Whitehouse, J. P., Hii, H. L., Mayoh, C., Wong, M., Ajuyah, P., Barahona, P., Cui, L., Dholaria, H., White, C. L., Buntine, M. K., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1123492 · Cited by 7
Bruschi, M. (2020) · Epigenomes · doi:10.3390/epigenomes4020008 · Cited by 7
Intracranial ependymomas: The role of advanced neuroimaging in diagnosis and management
Varrassi, M., Bellisari, F. C., Donato, M. C. D., Tommasino, E., Sibio, A. D., Bruno, F., Vitantonio, H. D., Splendiani, A., Cesare, E. D., & Masciocchi, C. (2021) · The Neuroradiology Journal · doi:10.1177/1971400921990770 · Cited by 7
Ahmad, Z., Rahim, S., Abdul‐Ghafar, J., Chundriger, Q., & Din, N. U. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s394872 · Cited by 7
Reduced H3K27me3 is a New Epigenetic Biomarker for Pediatric Posterior Fossa Ependymomas
Zhang, R. R., & Kuo, J. S. (2017) · Neurosurgery · doi:10.1093/neuros/nyx262 · Cited by 7
Chen, Q., Li, Z., Fu, Y., Lv, N., Tian, N., Han, L., & Tian, Y. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1652046 · Cited by 7
RetractedSavage, P. M. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00426 · Cited by 7
Advances in molecular prognostication and treatments in ependymoma
Bakes, E., Cheng, R., Manucat-Tan, N. B., Ramaswamy, V., & Hansford, J. R. (2025) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04923-9 · Cited by 6
Self-citationGestational trophoblastic disease: understanding the molecular mechanisms of placental tumours
Nicheperovich, A., Schuster‐Böckler, B., & Leathlobhair, M. N. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052010 · Cited by 6
Integrating ependymoma molecular subgroups into clinical trials
Venneti, S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz132 · Cited by 6
Corrêa, D. C. D. C., Tesser‐Gamba, F., Oliveira, I. D., da Silva, N. S., Capellano, A. M., Alves, M. T. D. S., Silva, F. A. B., Dastoli, P. A., Cavalheiro, S., & de Toledo, S. R. C. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03848-x · Cited by 6
Driver mutations in ADGRL3 are involved in the evolution of ependymoma
Wang, J., Xi, S. Y., Zhao, Q., Xia, Y., Yang, Q. T., Cai, H. Y., Wang, F., Zhao, Y.-Y., Yü, Z., Yu, Z.-H., et al. (2022) · Laboratory Investigation · doi:10.1038/s41374-021-00721-3 · Cited by 6
Self-citationPrader-Willi Syndrome: The Disease that Opened up Epigenomic-Based Preemptive Medicine
Kubota, T., Miyake, K., Hariya, N., Tran, N. Q. V., & Mochizuki, K. (2016) · Diseases · doi:10.3390/diseases4010015 · Cited by 6
Integrating Molecular Diagnostics With Surgical Neuropathology
Solomon, D. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-44941-0.00005-9 · Cited by 6
Brain Cancer-Activated Microglia: A Potential Role for Sphingolipids
Bottai, D., Adami, R., Paroni, R. C., & Ghidoni, R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190506120213 · Cited by 6
Metadata
- Authors
- Mack, S. C., Witt, H., Piro, R. M., Gu, L., Zuyderduyn, S., Stütz, A. M., Wang, X., Gallo, M., Garzia, L., Zayne, K., Zhang, X., Ramaswamy, V., Jäger, N., Jones, D. T. W., Sill, M., Pugh, T. J., Ryzhova, M., Wani, K. M., Shih, D. J. H., Head, R., Remke, M., Bailey, S. D., Zichner, T., Faria, C. C., Barszczyk, M., Stark, S., Seker-Cin, H., Hutter, S., Johann, P., Bender, S., Hovestadt, V., Tzaridis, T., Dubuc, A. M., Northcott, P. A., Peacock, J., Bertrand, K. C., Agnihotri, S., Cavalli, F. M. G., Clarke, I., Nethery-Brokx, K., Creasy, C. L., Verma, S. K., Koster, J., Wu, X., Yao, Y., Milde, T., Sin-Chan, P., Zuccaro, J., Lau, L., Pereira, S., Castelo-Branco, P., Hirst, M., Marra, M. A., Roberts, S. S., Fults, D., Massimi, L., Cho, Y. J., Van Meter, T., Grajkowska, W., Lach, B., Kulozik, A. E., von Deimling, A., Witt, O., Scherer, S. W., Fan, X., Muraszko, K. M., Kool, M., Pomeroy, S. L., Gupta, N., Phillips, J., Huang, A., Tabori, U., Hawkins, C., Malkin, D., Kongkham, P. N., Weiss, W. A., Jabado, N., Rutka, J. T., Bouffet, E., Korbel, J. O., Lupien, M., Aldape, K. D., Bader, G. D., Eils, R., Lichter, P., Dirks, P. B., Pfister, S. M., Korshunov, A., & Taylor, M. D.
- Affiliations
- University of Toronto (CA)
- German Cancer Research Center (DE)
- European Molecular Biology Laboratory (DE)
- Hospital for Sick Children (CA)
- Dartmouth–Hitchcock Medical Center (US)
- Boston Children's Hospital (US)
- The University of Texas MD Anderson Cancer Center (US)
- Ontario Institute for Cancer Research (CA)
- GlaxoSmithKline (United States) (US)
- BC Cancer Agency (CA)
- Uniformed Services University of the Health Sciences (US)
- University of Utah (US)
- Agostino Gemelli University Polyclinic (IT)
- Stanford Medicine (US)
- Children's Memorial Health Institute (PL)
- Hamilton General Hospital (CA)
- Heidelberg University (DE)
- University of Michigan (US)
- University of California, San Francisco (US)
- McGill University Health Centre (CA)
- Corresponding author
- Korshunov, A.
- Taylor, M. D.
- ORCID
- Mack, S. C.
- Witt, H.
- Piro, R. M.
- Gu, L.
- Stütz, A. M.
- Wang, X.
- Gallo, M.
- Garzia, L.
- Zhang, X.
- Ramaswamy, V.
- Jäger, N.
- Jones, D. T. W.
- Sill, M.
- Pugh, T. J.
- Ryzhova, M.
- Wani, K. M.
- Shih, D. J. H.
- Remke, M.
- Bailey, S. D.
- Zichner, T.
- Faria, C. C.
- Barszczyk, M.
- Hutter, S.
- Johann, P.
- Hovestadt, V.
- Tzaridis, T.
- Dubuc, A. M.
- Northcott, P. A.
- Bertrand, K. C.
- Agnihotri, S.
- Cavalli, F. M. G.
- Creasy, C. L.
- Verma, S. K.
- Wu, X.
- Yao, Y.
- Milde, T.
- Zuccaro, J.
- Lau, L.
- Pereira, S.
- Hirst, M.
- Marra, M. A.
- Roberts, S. S.
- Fults, D.
- Massimi, L.
- Cho, Y. J.
- Grajkowska, W.
- Lach, B.
- Kulozik, A. E.
- Witt, O.
- Scherer, S. W.
- Fan, X.
- Muraszko, K. M.
- Kool, M.
- Pomeroy, S. L.
- Gupta, N.
- Phillips, J.
- Huang, A.
- Tabori, U.
- Hawkins, C.
- Malkin, D.
- Kongkham, P. N.
- Weiss, W. A.
- Jabado, N.
- Rutka, J. T.
- Korbel, J. O.
- Lupien, M.
- Aldape, K. D.
- Bader, G. D.
- Eils, R.
- Lichter, P.
- Dirks, P. B.
- Pfister, S. M.
- Korshunov, A.
- Taylor, M. D.
- Venue
- Nature
- Published
- 2014-02
- Volume
- 506
- Issue
- 7489
- Pages
- 445-450
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4174313
- OpenAlex
- W2113432767
- Cited by
- 607
- References
- 50
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 30 · 2023: 29 · 2022: 37 · 2021: 51 · 2020: 56 · 2019: 55 · 2018: 68 · 2017: 64 · 2016: 73 · 2015: 57 · 2014: 40
- FWCI
- 39.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Pediatric Brain Tumor Foundation
- CureSearch for Children's Cancer
- Deutsches Krebsforschungszentrum
- Government of Ontario
- Bundesministerium für Bildung und Forschung (01KU1201A, 01GS0883)
- Terry Fox Research Institute
- Deutsche Krebshilfe (109252)
- Deutschen Konsortium für Translationale Krebsforschung
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01CA148699, R01CA148621, R01CA121941, R01CA163737, R01CA159859, P30CA016672, P50CA097257)
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- ependymoma, CpG island methylator phenotype, pediatric brain tumors, C11orf95-RELA fusion, chromothripsis, NF-κB signaling, H3K27me3, polycomb repressive complex 2, DNA methylation, EZH2 inhibitors, epigenetic therapy, tumor suppressor
- MeSH terms
- Animals, Brain Neoplasms, Ependymoma, Female, Histones, Humans, Infant, Mutation, Phenotype, Prognosis, Rhombencephalon, Gene Expression Regulation, Neoplastic, Mice, SCID, Mice, Inbred NOD, CpG Islands, DNA Methylation, Gene Silencing, Xenograft Model Antitumor Assays, Epigenesis, Genetic, Mice, Embryonic Stem Cells, Epigenomics, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
